| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 01/23/2003 | WO2003005883A2 Skin treatments using blue and violet light |
| 01/23/2003 | US20030018371 Compositions and methods for the treatment of metabolic bone disorders and bone metastases |
| 01/23/2003 | US20030017164 Dye-azide compounds for dual phototherapy |
| 01/23/2003 | US20030017152 Administering a substance that specifically depletes alpha beta -, and gamma delta -TCR+ T cells and/or CD8+ T cells, followed by transplantation with a donor cell preparation containing hematopoietic stem cells from a matched donor |
| 01/23/2003 | US20030017112 Porphyrin compounds |
| 01/23/2003 | CA2453474A1 Vegfr-1 antibodies to treat breast cancer |
| 01/22/2003 | EP1276749A1 Novel, photo-labile cumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof |
| 01/22/2003 | EP1276501A2 Method for treatment of tumors using photodynamic therapy |
| 01/22/2003 | CN1391929A Common man fat reducing food containing micro alternative biological electric field regulated bacterial strain |
| 01/22/2003 | CN1391839A Fat woman fat-reducing food contaiing micro alternating biological electric field regulated bacterial strain |
| 01/22/2003 | CN1391838A Common woman fat-reducing food containing micro alternating biological electric field regualted bacterial strain |
| 01/22/2003 | CN1391837A Fat man fat-reducing food containing micro alternating biological electric field regualted bacterial strain |
| 01/21/2003 | US6508785 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 01/16/2003 | WO2003004466A2 Dye-sulfenates for dual phototherapy |
| 01/16/2003 | WO2003004091A2 Aromatic sulfenates for type i phototherapy |
| 01/16/2003 | WO2003004021A1 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 01/16/2003 | WO2003003975A2 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 01/16/2003 | WO2003003806A2 Dye-azide compounds for dual phototherapy |
| 01/16/2003 | WO2002045724A3 Use of modified mammalian blood for treating transforming growth factor related diseases |
| 01/16/2003 | WO2002022107A3 Pharmaceutical composition having modified carrier |
| 01/16/2003 | US20030013739 Synergistic mixtures; side effect reduction |
| 01/16/2003 | US20030013696 Methods and compositions for photo-cross linking photoactive compounds to target tissue |
| 01/16/2003 | US20030012325 Mixture containing rare earth and the use thereof |
| 01/16/2003 | CA2452835A1 Aromatic sulfenates for type i phototherapy |
| 01/16/2003 | CA2452644A1 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 01/16/2003 | CA2449828A1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 01/15/2003 | EP1274410A2 Use of locally applied dna fragments |
| 01/14/2003 | US6506791 Method of treatment of protozoan infections in fish |
| 01/09/2003 | WO2003002156A2 Contrast agents comprising metal particles encapsulated in microspheres for use in medical diagnostic imaging and therapy |
| 01/09/2003 | WO2003002145A1 Diagnosis and treatment of insulin-dependent diabetes mellitus and insulitis |
| 01/09/2003 | WO2002096365A9 Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy |
| 01/09/2003 | WO2001098294A3 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 01/09/2003 | US20030009158 Skin treatments using blue and violet light |
| 01/09/2003 | US20030009155 Method for accurate optical treatment of an eye's fundus |
| 01/09/2003 | US20030008857 Exposing target cells to photosensitizer; allowing photosensitizer to localize in target cells; irradiating target cells with light absorbed by photosensitizer to induce apoptosis; contacting cells with apoptosis-inducing agent |
| 01/09/2003 | CA2455654A1 Diagnosis and treatment of insulin-dependent diabetes mellitus and insulitis |
| 01/08/2003 | EP1272200A1 Divided dose therapies with vascular damaging activity |
| 01/08/2003 | EP1272199A1 Combination therapies with vascular damaging activity |
| 01/08/2003 | EP1272193A2 Synergistic methods and compositions for treating cancer |
| 01/08/2003 | EP1272178A2 Bilirubin or biliverdin degradation fragments |
| 01/08/2003 | CN1098068C Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 01/07/2003 | US6503886 Gene delivery; polypeptide conjugated to fibroblast growth factor fused to nucleic acid |
| 01/07/2003 | US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 01/07/2003 | US6503699 Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens |
| 01/07/2003 | CA2164844C Methods of preparing gas-filled liposomes |
| 01/06/2003 | WO2003004559A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/06/2003 | CA2445824A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 01/03/2003 | WO2002013863A3 Presbyopia treatment by lens alteration |
| 01/02/2003 | US20030004556 Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen |
| 01/02/2003 | US20030004334 Water-soluble porphyrin derivatives and methods of their preparation |
| 01/02/2003 | US20030003435 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 01/02/2003 | US20030003102 Morpholino imaging and therapy |
| 01/02/2003 | US20030003055 Shaking an aqueous solution comprising a phospholipid and a polymer, in the presence of a gas, at a temperature below the gel state to liquid crystalline transition temperature of the lipid |
| 01/02/2003 | US20030003054 Suitable for use as a contrast agent with a plurality of imaging modalities, including, for example, ultrasound, magnetic resonance imaging, and computed temography; neutron capture therapy |
| 01/02/2003 | US20030003047 Tumor radiotherapy |
| 01/02/2003 | EP1268467A1 Heteroaromatic compounds having two-photon absorption activity |
| 01/02/2003 | EP1267935A2 Novel treatment for eye disease |
| 01/02/2003 | EP1267933A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 01/02/2003 | EP1267931A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 01/02/2003 | EP1267897A1 Treatment of congestive heart failure by pretreated autologous blood |
| 12/31/2002 | US6500816 Remedies for photochemotherapy |
| 12/31/2002 | US6500800 Composition and method for causing photodynamic damage to target cells |
| 12/26/2002 | US20020198567 Electro-endocytotic therapy as a treatment modality of cancer |
| 12/26/2002 | US20020198135 Compositions for release of radiosensitizers, and methods of making and using the same |
| 12/26/2002 | US20020197335 Antioxidants in clusters of structured water |
| 12/26/2002 | US20020197262 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies |
| 12/26/2002 | US20020197216 Cross-regulin composition of turmeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays |
| 12/24/2002 | US6498945 Free radical generation of water soluble polymer to enhance cytopathogenic efficacy |
| 12/24/2002 | US6498181 Enhancing humoral immune response in combination with cancer therapy including surgery, radiation and immunotherapy |
| 12/19/2002 | WO2002100478A2 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species |
| 12/19/2002 | WO2002100326A2 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies |
| 12/19/2002 | US20020193850 Use of photodynamic therapy to treat prostatic tissue |
| 12/19/2002 | US20020193784 Ultrasound therapy for selective cell ablation |
| 12/19/2002 | US20020193416 Synergistic tumorcidal response induced by histamine |
| 12/19/2002 | US20020192313 Use of legume products for the treatment of external aggressions |
| 12/19/2002 | US20020192289 Polymer gel for cancer treatment |
| 12/19/2002 | CA2450370A1 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species |
| 12/19/2002 | CA2445898A1 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies |
| 12/18/2002 | EP1265636A2 Improved treatment of neovascularization |
| 12/18/2002 | EP1265546A1 Methods and apparatus for optical imaging |
| 12/17/2002 | US6495585 Method for treating hyperproliferative tissue in a mammal |
| 12/17/2002 | US6495527 Enhancing binding ability of a protein, such as human serum albumin; therapeutic agent carrier |
| 12/17/2002 | US6495129 Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3) |
| 12/17/2002 | US6494878 System and method for accurate optical treatment of an eye's fundus |
| 12/12/2002 | WO2002098882A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 12/12/2002 | WO2002098501A2 Method and apparatus for treating tumors using low strength electric fields |
| 12/12/2002 | WO2002098417A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 12/12/2002 | WO2002082044A3 Method of imaging cell death in vivo |
| 12/12/2002 | WO2002076508B1 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 12/12/2002 | US20020188021 Method of using caffeic acid phenethyl ester and analogs thereof as radiation sensitizers |
| 12/12/2002 | US20020187993 Bifunctional energy-reversible acyl-compositions |
| 12/12/2002 | US20020187992 Prodrugs via acylation with cinnamate |
| 12/12/2002 | US20020187347 Multi-layer nanoshells |
| 12/12/2002 | DE10127544A1 Photodynamic therapy used for killing tumor cells in humans, by application of light in presence of carbonyl-substituted chlorin compound as oxidation stable photosensitizer |
| 12/12/2002 | CA2450009A1 Method and apparatus for treating tumors using low strength electric fields |
| 12/12/2002 | CA2449316A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 12/11/2002 | EP1263761A2 Compounds for pdt |
| 12/11/2002 | EP1263465A2 Photodynamic cellular and acellular organism eradication using a photosensitive material and surfactant |
| 12/11/2002 | EP1263450A1 Method and apparatus for inducing a cellular response |
| 12/11/2002 | EP1263447A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods |